Edesa Biotech, Inc. (EDSA)
4.76
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 16:00
4.76
0.00 (0.00%)
After-Hours: 20:00
Edesa Biotech Shareholders Equity (Quarterly) : 8.811M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.811M |
| March 31, 2026 | 10.20M |
| December 31, 2025 | 13.95M |
| September 30, 2025 | 12.45M |
| June 30, 2025 | 14.13M |
| March 31, 2025 | 15.54M |
| December 31, 2024 | 2.264M |
| September 30, 2024 | 1.981M |
| June 30, 2024 | 2.867M |
| March 31, 2024 | 4.324M |
| December 31, 2023 | 5.845M |
| September 30, 2023 | 7.049M |
| June 30, 2023 | 7.850M |
| March 31, 2023 | 9.000M |
| December 31, 2022 | 10.27M |
| September 30, 2022 | 9.391M |
| June 30, 2022 | 11.84M |
| March 31, 2022 | 17.02M |
| December 31, 2021 | 10.55M |
| September 30, 2021 | 13.06M |
| June 30, 2021 | 15.80M |
| March 31, 2021 | 19.27M |
| December 31, 2020 | 9.257M |
| September 30, 2020 | 9.108M |
| June 30, 2020 | 7.800M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.931M |
| December 31, 2019 | 4.234M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | 8.270M |
| December 31, 2018 | 9.908M |
| September 30, 2018 | 11.29M |
| June 30, 2018 | 12.39M |
| March 31, 2018 | 4.74M |
| December 31, 2017 | 6.019M |
| September 30, 2017 | 7.399M |
| June 30, 2017 | 8.597M |
| March 31, 2017 | 9.790M |
| December 31, 2016 | 10.86M |
| September 30, 2016 | 12.31M |
| June 30, 2016 | 7.661M |
| March 31, 2016 | 8.813M |
| December 31, 2015 | 9.631M |
| September 30, 2015 | 8.005M |
| June 30, 2015 | 9.433M |
| March 31, 2015 | 8.923M |
| December 31, 2014 | 9.237M |
| August 31, 2014 | 7.701M |
| May 31, 2014 | 11.15M |
| February 28, 2014 | 9.131M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ProMIS Neurosciences, Inc. | 49.40M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.72M |
| Total Liabilities (Quarterly) | 3.91M |
| Current Ratio | 2.757 |